Pulmonary Vasculature

Latest News

Pregnancy-Adapted Algorithm Avoids Diagnostic Imaging for PE

Suspected pulmonary embolism safely ruled out in some pregnant women with diagnostic algorithm.

Making the Case for Earlier Palliative Care in PAH: A Clinical Opinion

A clinician shares his experience with palliative care in cardiology and makes the case for offering palliative care services earlier in pulmonary arterial hypertension.

Balloon Pulmonary Angioplasty Safely Treats CTEPH in Older Patients

Balloon pulmonary angioplasty was considered safe and effective even in patients considered “oldest-old” with chronic thromboembolic pulmonary hypertension.

Sleep Apnea Severity Linked to Elevated Pulmonary Capillary Wedge Pressure

Sleep apnea severity was associated with elevated pulmonary capillary wedge pressure in adults.

Macitentan Improves Right Ventricular Function in PAH

Macitentan improved right ventricular function in patients with pulmonary arterial hypertension.

Gender, Age, and Etiology Do Not Affect Response to PAH Treatment

Age, gender, and etiology significantly influence prognosis together with the recently validated simplified PAH risk table but don’t significantly influence the response to PAH-specific treatment.

Better Guidelines for Diagnosing Pulmonary Embolism During Pregnancy Needed

Current guidelines to diagnosis pulmonary embolism in pregnant patients offer conflicting recommendations.

Case Study: Man Presents With Hypertension, AF, and Shortness of Breath

A 63-year-old man with hypertension and paroxysmal atrial fibrillation presents with several months of worsening shortness of breath. He states that any physical activity makes him short of breath, including walking from his bed to a chair a few feet away. On physical exam, his heart rate is 65 beats per minute, blood pressure is…

Heart-Lung vs Double-Lung Transplant Outcomes in Pulmonary Hypertension

Individuals with pulmonary hypertension experienced lower primary graft dysfunction following heart-lung transplantation compared with double-lung transplantation.

Pulmonary Arterial Hypertension Risk Better Predicted by REVEAL 2.0

The REVEAL 2.0 three category score was better at discriminating risks in patients with pulmonary arterial hypertension than similar tools such as COMPERA and FPHR.